Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: The Study of Atrial Fibrillation Reduction (SAFARI)

American Heart Journal

Volumn 152, Issue 2, 2006, Pages 231-236

  Gold, Michael R ^a,b   Hoffmann, Ellen ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b KLINIKUM BOGENHAUSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; MULTICENTER STUDY; POPULATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; EQUIPMENT DESIGN; HUMANS; MULTICENTER STUDIES; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC;

EID: 33746238824     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.11.012     Document Type: Article

References (23)

1. Israel C.W., and Hohnloser S.H. Pacing to prevent atrial fibrillation. J Cardiovasc Electrophysiol 14 (2003) S20-S26
2. Knight B.P., Gersh B.J., Carlson M.D., et al. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 111 (2005) 240-243
3. Savelieva I., and Camm A.J. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough?. J Interv Card Electrophysiol 8 (2003) 103-115
4. Yang A., Lüderitz B., and Lewalter T. Atrial fibrillation: profit from cardiac pacing?. Z Kardiol 94 (2005) 141-151
5. Mitchell A.R.J., and Sulke N. How do atrial pacing algorithms prevent atrial arrhythmias?. Europace 6 (2004) 351-362
6. Gregoratos G., Cheitlin M.D., Conill A., et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 97 (1998) 1325-1335
7. Sweeney M., Hellkamp A., Ellenbogen K., et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107 (2003) 2932-2937
8. Anderson H.R., Nielsen J.C., Thomsen P.E.B., et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 350 (1997) 1210-1216
9. Rosenqvist M., Brandt J., and Schüller H. Atrial versus ventricular pacing in sinus node disease: a treatment comparison study. Am Heart J 111 (1986) 292-297
10. Purerfellner H., Gillis A.M., Holbrook R., et al. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol 27 (2004) 983-992
11. Carlioz R., Perrier E., Thomas O., et al. Accuracy of atrial tachyarrhythmia monitoring in the selection device: correlation with an external Holter monitor. In: Thomsen P.E.B. (Ed). Europace 2001 (2001), Monduzzi Editore S.p.A.-Medimond, Inc, Bologna (Italy) 419-423
12. Hettrick D.A., Orlov M.V., Ghali J., et al. Bi-modal distribution of atrial tachyarrhythmia burden in the pacemaker population: are traditional statistical analysis of arrhythmia recurrence valid?. Heart Rhythm 2 (2005) S282
13. Conover W.J. Practical nonparametric statistics. 2nd ed. (1980), Wiley, New York 291
14. Skanes A.C., Krahn A.D., Yee R., et al. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. J Am Coll Cardiol 38 (2001) 167-172
15. Connolly S.J., Kerr C.R., Gent M., et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 342 (2000) 1385-1391
16. Nielsen J.C., Kristensen L., Andersen H.R., et al. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol 42 (2003) 614-623
17. Blanc J.-J., De Roy L., Mansourati J., et al. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 6 (2004) 371-379
18. Mehra R. How might pacing prevent atrial fibrillation?. In: Murgatroyd F.D., and Camm A.J. (Eds). Nonpharmacological management of atrial fibrillation (1997), Futura Publishing Co, Inc, Armonk (NY) 283-307
19. Allessie M.A., Boyden P.A., Camm A.J., et al. Pathophysiology and prevention of atrial fibrillation. Circulation 103 (2001) 769-777
20. Lee M.A., Weachter R., Pollak S., et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 41 (2003) 1926-1932
21. Padeletti L., Pürerfellner H., Adler S.W., et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 14 (2003) 1189-1195
22. Carlson M.D., Ip J., Messenger J., et al. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 42 (2003) 627-633
23. De Voogt W, De Vusser P, Lau CP, et al. OASES trial: overdrive atrial septum stimulation in patients with paroxysmal atrial fibrillation and class 1 and class 2 pacemaker indication. Program and abstracts from NASPE 2003-24th Annual Scientific Sessions; May 14-17, 2003; Washington, DC. Late Breaking Clinical Trials.